Arun Sawhney, managing director and chief executive officer, Ranbaxy continues to deny any wrong doing. He says the USFDA's ban on its products is due to different definitions of what is 'adulterated' in the US and in India.
first published: Jun 19, 2013 05:58 pm
A collection of the most-viewed Moneycontrol videos.
EU Ramps Up Ukraine Aid, Tomahawk Missiles as Trump-Putin Ceasefire Talks Risk Donbas Territory Loss
Samvat 2082 LIVE | Muhurat Trading LIVE | Diwali 2025 | Investment Strategies
Samvat 2082: What To Expect In The New Year | Diwali Muhurat Trading
Diwali Cheer Extends For Fourth Day| Nifty Hits 25,900 Intra-day, Banks Party| Closing Bell Live
